Free Trial

Telix Pharmaceuticals Limited American Depositary Shares (TLX) Competitors

Telix Pharmaceuticals Limited American Depositary Shares logo
$18.30 -0.06 (-0.33%)
Closing price 03/26/2025 04:00 PM Eastern
Extended Trading
$18.30 0.00 (0.00%)
As of 03/26/2025 07:16 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TLX vs. TEVA, SMMT, ITCI, GMAB, MRNA, VTRS, RDY, ASND, SRPT, and PCVX

Should you be buying Telix Pharmaceuticals Limited American Depositary Shares stock or one of its competitors? The main competitors of Telix Pharmaceuticals Limited American Depositary Shares include Teva Pharmaceutical Industries (TEVA), Summit Therapeutics (SMMT), Intra-Cellular Therapies (ITCI), Genmab A/S (GMAB), Moderna (MRNA), Viatris (VTRS), Dr. Reddy's Laboratories (RDY), Ascendis Pharma A/S (ASND), Sarepta Therapeutics (SRPT), and Vaxcyte (PCVX). These companies are all part of the "pharmaceutical products" industry.

Telix Pharmaceuticals Limited American Depositary Shares vs.

Teva Pharmaceutical Industries (NYSE:TEVA) and Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, community ranking, institutional ownership, analyst recommendations, earnings, profitability, media sentiment and dividends.

Teva Pharmaceutical Industries presently has a consensus target price of $23.43, indicating a potential upside of 49.46%. Telix Pharmaceuticals Limited American Depositary Shares has a consensus target price of $22.00, indicating a potential upside of 20.22%. Given Teva Pharmaceutical Industries' higher possible upside, research analysts plainly believe Teva Pharmaceutical Industries is more favorable than Telix Pharmaceuticals Limited American Depositary Shares.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Teva Pharmaceutical Industries
0 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.86
Telix Pharmaceuticals Limited American Depositary Shares
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Teva Pharmaceutical Industries had 16 more articles in the media than Telix Pharmaceuticals Limited American Depositary Shares. MarketBeat recorded 22 mentions for Teva Pharmaceutical Industries and 6 mentions for Telix Pharmaceuticals Limited American Depositary Shares. Telix Pharmaceuticals Limited American Depositary Shares' average media sentiment score of 0.82 beat Teva Pharmaceutical Industries' score of 0.75 indicating that Telix Pharmaceuticals Limited American Depositary Shares is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Teva Pharmaceutical Industries
10 Very Positive mention(s)
0 Positive mention(s)
11 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Telix Pharmaceuticals Limited American Depositary Shares
2 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

54.0% of Teva Pharmaceutical Industries shares are held by institutional investors. 0.6% of Teva Pharmaceutical Industries shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Telix Pharmaceuticals Limited American Depositary Shares has lower revenue, but higher earnings than Teva Pharmaceutical Industries.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Teva Pharmaceutical Industries$16.54B1.07-$1.64B-$1.45-10.81
Telix Pharmaceuticals Limited American Depositary Shares$783.21M7.87N/AN/AN/A

Teva Pharmaceutical Industries received 1329 more outperform votes than Telix Pharmaceuticals Limited American Depositary Shares when rated by MarketBeat users. However, 100.00% of users gave Telix Pharmaceuticals Limited American Depositary Shares an outperform vote while only 67.84% of users gave Teva Pharmaceutical Industries an outperform vote.

CompanyUnderperformOutperform
Teva Pharmaceutical IndustriesOutperform Votes
1333
67.84%
Underperform Votes
632
32.16%
Telix Pharmaceuticals Limited American Depositary SharesOutperform Votes
4
100.00%
Underperform Votes
No Votes

Telix Pharmaceuticals Limited American Depositary Shares has a net margin of 0.00% compared to Teva Pharmaceutical Industries' net margin of -9.91%. Teva Pharmaceutical Industries' return on equity of 42.46% beat Telix Pharmaceuticals Limited American Depositary Shares' return on equity.

Company Net Margins Return on Equity Return on Assets
Teva Pharmaceutical Industries-9.91% 42.46% 6.65%
Telix Pharmaceuticals Limited American Depositary Shares N/A N/A N/A

Summary

Teva Pharmaceutical Industries beats Telix Pharmaceuticals Limited American Depositary Shares on 9 of the 14 factors compared between the two stocks.

Remove Ads
Get Telix Pharmaceuticals Limited American Depositary Shares News Delivered to You Automatically

Sign up to receive the latest news and ratings for TLX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TLX vs. The Competition

MetricTelix Pharmaceuticals Limited American Depositary SharesPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$6.16B$6.90B$5.62B$8.13B
Dividend YieldN/A2.73%4.56%4.00%
P/E RatioN/A7.1824.5419.09
Price / Sales7.87226.87386.7694.71
Price / CashN/A65.6738.1634.64
Price / BookN/A6.486.974.36
Net IncomeN/A$142.41M$3.20B$247.23M
7 Day Performance4.39%-2.89%-2.19%-0.34%
1 Month Performance-3.17%-4.52%3.14%-3.60%
1 Year PerformanceN/A-8.69%11.39%2.01%

Telix Pharmaceuticals Limited American Depositary Shares Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TLX
Telix Pharmaceuticals Limited American Depositary Shares
N/A$18.30
-0.3%
$22.00
+20.2%
N/A$6.16B$783.21M0.00N/AGap Up
TEVA
Teva Pharmaceutical Industries
2.5962 of 5 stars
$16.74
+2.5%
$23.43
+40.0%
+10.8%$18.97B$16.54B-11.5436,800Analyst Downgrade
Short Interest ↑
SMMT
Summit Therapeutics
2.6953 of 5 stars
$20.13
-3.2%
$34.11
+69.5%
+431.8%$14.85B$700,000.00-71.89110Analyst Upgrade
News Coverage
Gap Up
ITCI
Intra-Cellular Therapies
3.6489 of 5 stars
$131.45
+0.1%
$106.08
-19.3%
+95.6%$13.98B$680.50M-151.09560Positive News
GMAB
Genmab A/S
4.068 of 5 stars
$20.80
+1.4%
$41.33
+98.7%
-36.4%$13.76B$21.53B11.952,204Short Interest ↑
Gap Down
MRNA
Moderna
4.1218 of 5 stars
$34.71
+0.3%
$59.60
+71.7%
-70.7%$13.39B$3.20B-3.743,900
VTRS
Viatris
1.8801 of 5 stars
$9.25
+1.6%
$10.50
+13.5%
-22.8%$11.04B$14.74B-12.5037,000Short Interest ↑
RDY
Dr. Reddy's Laboratories
3.4752 of 5 stars
$13.23
+4.3%
$17.00
+28.5%
-8.8%$11.04B$311.31B21.0624,800Positive News
ASND
Ascendis Pharma A/S
2.946 of 5 stars
$168.84
+10.4%
$202.36
+19.9%
+5.5%$10.25B$363.64M-23.781,017Positive News
High Trading Volume
SRPT
Sarepta Therapeutics
4.8507 of 5 stars
$101.35
+4.3%
$170.41
+68.1%
-43.2%$9.83B$1.90B81.081,314
PCVX
Vaxcyte
2.0514 of 5 stars
$75.23
+1.2%
$147.50
+96.1%
+1.7%$9.69BN/A-16.35160Positive News
Remove Ads

Related Companies and Tools


This page (NASDAQ:TLX) was last updated on 3/27/2025 by MarketBeat.com Staff
From Our Partners